查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403415

關節止痛注射市場至2030年的預測：按關節類型、注射類型、配銷通路、最終用戶和地區的全球分析

Joint Pain Injections Market Forecasts to 2030 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球關節止痛注射市場規模為 52 億美元，預計到2030年將達到 107 億美元，預測期內年複合成長率為 10.6%。

直接注射到關節用於治療關節疼痛，減少腫脹和發炎。在老年人中，關節不適通常是由原有疾病引起的。關節炎是一種廣泛傳播的疾病，主要影響脊椎的髖關節、膝關節、肘關節、肩關節和小關節。關節炎會導致關節發炎和不舒服。

根據英國關節炎研究中心的報告《2018年肌肉骨骼健康狀況》，估計英國有1,780萬人患有肌肉骨骼疾病，約佔全國總人口的28.9%。

關節炎增加

關節炎是全世界成年人殘疾最常見的原因。例如，皮質類固醇或透明質酸注射可以透過潤滑關節和減少發炎來顯著減輕疼痛並緩解僵硬和不適。透過仔細地將藥物給藥到疼痛或發炎區域，注射針對受影響的關節，提高療效並最大限度地減少全身副作用。在此背景下，市場規模不斷擴大。

副作用和過敏

關節止痛注射患者所經歷的副作用和過敏是市場擴張的主要障礙。一些因關節疼痛而接受注射的患者的軟骨和神經受到損傷，這影響了這些醫療設備的生產和銷售。此外，產業擴張的最大障礙是患者使用關節止痛注射劑導致的皮膚變色和感染疾病。

關節相關疾病的盛行率增加

市場促進因素之一是關節相關疾病的盛行率不斷增加。骨關節炎和類風濕性關節炎等疾病的發生率不斷增加，對有效的疼痛管理解決方案（包括關節疼痛注射）產生了巨大的需求。人口高齡化、久坐生活方式和運動相關傷害的增加進一步促進了市場成長。

缺乏知識

一般人從未聽過注射治療關節疼痛。富含血小板的血漿、皮質類固醇和透明質酸注射用於緩解關節不適。使用這些注射需要大量的專業知識和培訓。醫生和其他醫療專業人員經常因關節不適而給患者注射。專業人員將獲得完成此任務所需的工具和培訓。然而，由於政府缺乏鼓勵注射治療關節疼痛的措施，市場成長有限。

COVID-19 的影響：

事實證明，COVID-19 大流行是一場獨特的全球公共衛生災難，幾乎影響了所有企業，其影響預計將在預測期內影響每個行業的成長。在全球範圍內，供應鏈途徑、採購模式、客戶需求和行為以及政府關鍵措施發生一些變化。疫情改變了人們的生活方式、用藥方式以及其他與健康相關的習慣。

透明質酸注射細分市場預計將成為預測期內最大的細分市場

預計透明質酸注射領域在預測期內將是最大的。已經嘗試過對乙醯胺酚和其他鴉片類藥物等無效治療的患者接受透明質酸注射治療，以治療與骨關節炎相關的膝蓋不適。透明質酸注射作為一種非手術治療選擇逐漸普及，特別是考慮到醫生通常不願意常規進行關節內皮質類固醇注射。

預計醫院藥房領域在預測期內的年複合成長率最高。

預計醫院藥房領域在預測期內的年複合成長率最高。除了有能力的藥劑師外，醫院藥局還經常聘請接受腸外藥物給藥特殊培訓的醫療專業人員，這可以確保正確的技術並減少出現問題的機會。患者可以獲得更廣泛的疼痛管理選擇，包括根據其特定需求量身定做的不同類型的注射和聯合治療。

佔有率最大的地區

由於肌肉骨骼疾病的高盛行率和老年人口的增加，預計北美在預測期內將佔據最大的市場佔有率。這是由於該地區市場參與企業的高度集中，該地區行業參與者的強大影響力，醫療保健基礎設施的改善，公眾和行業利益相關者對可用技術的更多了解，等多種因素造成。該地區的市場也因為最尖端科技的高採用率而不斷擴大。

年複合成長率最高的地區：

預計亞太地區在預測期內將維持最高的年複合成長率。骨關節炎盛行率的上升以及區域競爭企業進入黏性補充品產品推動每個國家市場的成長。此外，有關尖端關節疼痛治療的知識的普及為患者接受這些治療方法創造了理想的環境。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球關節止痛注射市場：依關節類型

  • 肩膀和肘部
  • 脊椎的椎間關節
  • 膝蓋和腳踝
  • 髖關節
  • 其他關節類型

第6章 全球關節止痛注射市場：按注射類型

  • 白細胞介素抑制劑
  • 玻尿酸注射
  • 類固醇關節注射
  • 富血小板血漿（PRP）注射
  • 胎盤組織基質（PTM）注射
  • 其他注射類型

第7章 全球關節止痛注射市場：依配銷通路

  • 零售藥房
  • 醫院藥房
  • 網路藥房

第8章 全球關節止痛注射市場：依最終用戶分類

  • 醫院
  • 診所
  • 其他最終用戶

第9章 全球關節止痛注射市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Anika Therapeutics, Inc.
  • Sanofi aventis LLC
  • Ferring BV
  • Zimmer Biomet
  • Bioventus LLC
  • Allergen Plc.
  • Pfizer Inc.
  • Chugai Pharmaceutical Co. Ltd
  • SEIKAGAKU Corporation
  • Ferring BV
  • Pacira Biosciences
  • OrthogenRx
  • Pfizer
  • Lifecore Biomedical
  • Wright Medical Group
  • AbbVie
  • Stryker
Product Code: SMRC24640

According to Stratistics MRC, the Global Joint Pain Injections Market is accounted for $5.2 billion in 2023 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 10.6% during the forecast period. Direct injections into the joints are used to treat joint pain in order to reduce swelling and inflammation. In the elderly population, joint discomfort is typically brought on by pre-existing conditions. The widespread ailment known as arthritis mostly affects the hip, knee, elbow, shoulder, and facet joints of the spine. It causes inflammation in the joints and makes them uncomfortable.

According to the Arthritis Research UK report, "The State of Musculoskeletal Health 2018", it is estimated that 17.8 million people suffer with a musculoskeletal condition in the UK which is around 28.9% of the total population of the country.

Market Dynamics:

Driver:

Increased occurrence of arthritis

The most frequent cause of adult disability worldwide is arthritis. Corticosteroids and hyaluronic acid injections, for example, can significantly reduce pain by lubricating the joints and decreasing inflammation, which relieves stiffness and discomfort. By carefully administering medicine to the region of pain or inflammation, injections target the afflicted joint, increasing efficacy and minimizing systemic adverse effects. The market is expanding as a result of these causes.

Restraint:

Side effects and allergies

Joint pain injection side effects and allergies that patients experienced have turned out to be a significant barrier to the market's expansion. Some patients who had joint pain injections had damage to their cartilage and nerves, which has had an impact on the manufacturing and marketing of these medical devices. Furthermore, the largest obstacle to the industry's expansion has been shown to be skin discoloration and infections that result from patients using joint pain inoculations.

Opportunity:

Growing prevalence of joint-related disorders

One driver of the market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

Threat:

Lack of knowledge

The average population has never heard about joint pain injections. Platelet-rich plasma, corticosteroids, and hyaluronic acid injections are used to relieve joint discomfort. To utilize these injections, one must possess a great deal of expertise and training. Physicians and other medical professionals frequently inject people for joint discomfort. The tools and training needed for professionals to do this are supplied. The lack of government measures to encourage joint pain injections, however, limits the market's growth.

COVID-19 Impact:

The COVID-19 pandemic has turned out to be an unparalleled worldwide public health disaster that has impacted practically every business, and its repercussions are anticipated to have an impact on every industry's growth over the projection period. Globally, there have been several shifts in supply chain rerouting, purchasing patterns, customer demand and behavior, and major government efforts. The epidemic has altered people's lifestyles, drug usage patterns, and other health-related habits.

The hyaluronic acid injections segment is expected to be the largest during the forecast period

The hyaluronic acid injections segment is expected to be the largest during the forecast period. Patients who have already tried ineffective treatments like acetaminophen and other opioids are treated with hyaluronic acid injections for knee discomfort associated with osteoarthritis. Injections of hyaluronic acid have grown in favor as a non-surgical treatment option, especially considering that physicians are generally reluctant to administer intraarticular corticosteroid injections on a regular basis.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies frequently employ medical professionals with specific training in injectable administration in addition to competent pharmacists, assuring correct technique and lowering the chance of problems. Patients have access to a wider range of pain management options, including different types of injections or combination therapies tailored to their specific needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the high prevalence of musculoskeletal disorders, growing geriatric population. This is ascribed to a number of factors, including the large concentration of market participants in the area, the robust presence of industry companies in the area, improved healthcare infrastructure, and public and industry stakeholder knowledge of available technology. The market in this area is expanding due in part to a high rate of adoption of cutting-edge technology.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The rising incidence of osteoarthritis and the entry of viscosupplement products by regional competitors are propelling the growth of the respective markets in each country. Furthermore, ideal circumstances for the patient population's acceptance of these therapies are created by the growing knowledge of cutting-edge joint pain treatments in the area.

Key players in the market:

Some of the key players in Joint Pain Injections market include Anika Therapeutics, Inc., Sanofi aventis LLC, Ferring B.V., Zimmer Biomet, Bioventus LLC, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, Ferring B.V., Pacira Biosciences, OrthogenRx, Pfizer, Lifecore Biomedical, Wright Medical Group, AbbVie and Stryker.

Key Developments:

In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.

In March 2022, Sanofi collaborated with IGM Biosciences Inc. to develop, manufacture, and introduce potential therapeutics in the fields of immunology and inflammation.

Joint Types Covered:

  • Shoulder and Elbow
  • Facet Joints of the Spine
  • Knee and Ankle
  • Hip Joint
  • Other Joint Types

Injection Types Covered:

  • Interleukin Inhibitors
  • Hyaluronic Acid Injections
  • Steroid Joint Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Other Injection Types

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

End Users Covered:

  • Hospitals
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introducton
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Joint Pain Injections Market, By Joint Type

  • 5.1 Introduction
  • 5.2 Shoulder and Elbow
  • 5.3 Facet Joints of the Spine
  • 5.4 Knee and Ankle
  • 5.5 Hip Joint
  • 5.6 Other Joint Types

6 Global Joint Pain Injections Market, By Injection Type

  • 6.1 Introduction
  • 6.2 Interleukin Inhibitors
  • 6.3 Hyaluronic Acid Injections
  • 6.4 Steroid Joint Injections
  • 6.5 Platelet-rich Plasma (PRP) Injections
  • 6.6 Placental Tissue Matrix (PTM) Injections
  • 6.7 Other Injection Types

7 Global Joint Pain Injections Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Online Pharmacies

8 Global Joint Pain Injections Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Other End Users

9 Global Joint Pain Injections Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Anika Therapeutics, Inc.
  • 11.2 Sanofi aventis LLC
  • 11.3 Ferring B.V.
  • 11.4 Zimmer Biomet
  • 11.5 Bioventus LLC
  • 11.6 Allergen Plc.
  • 11.7 Pfizer Inc.
  • 11.8 Chugai Pharmaceutical Co. Ltd
  • 11.9 SEIKAGAKU Corporation
  • 11.10 Ferring B.V.
  • 11.11 Pacira Biosciences
  • 11.12 OrthogenRx
  • 11.13 Pfizer
  • 11.14 Lifecore Biomedical
  • 11.15 Wright Medical Group
  • 11.16 AbbVie
  • 11.17 Stryker

List of Tables

  • Table 1 Global Joint Pain Injections Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 3 Global Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 4 Global Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 5 Global Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 6 Global Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 7 Global Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 8 Global Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 9 Global Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 10 Global Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 11 Global Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 12 Global Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 13 Global Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 14 Global Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 15 Global Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 16 Global Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 17 Global Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 18 Global Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 19 Global Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 22 Global Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 25 North America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 26 North America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 27 North America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 28 North America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 29 North America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 30 North America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 31 North America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 32 North America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 33 North America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 34 North America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 35 North America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 36 North America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 37 North America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 38 North America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 39 North America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 40 North America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 41 North America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 44 North America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 47 Europe Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 48 Europe Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 49 Europe Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 50 Europe Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 51 Europe Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 52 Europe Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 53 Europe Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 54 Europe Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 55 Europe Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 56 Europe Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 57 Europe Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 58 Europe Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 59 Europe Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 60 Europe Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 61 Europe Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 62 Europe Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 63 Europe Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 66 Europe Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 70 Asia Pacific Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 71 Asia Pacific Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 72 Asia Pacific Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 73 Asia Pacific Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 74 Asia Pacific Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 76 Asia Pacific Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 77 Asia Pacific Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 78 Asia Pacific Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 79 Asia Pacific Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 80 Asia Pacific Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 81 Asia Pacific Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 Asia Pacific Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 83 Asia Pacific Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 84 Asia Pacific Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 85 Asia Pacific Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 88 Asia Pacific Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 91 South America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 92 South America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 93 South America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 94 South America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 95 South America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 96 South America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 97 South America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 98 South America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 99 South America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 100 South America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 101 South America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 102 South America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 103 South America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 104 South America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 105 South America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 106 South America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 107 South America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 110 South America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 114 Middle East & Africa Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 115 Middle East & Africa Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 116 Middle East & Africa Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 117 Middle East & Africa Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 118 Middle East & Africa Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 119 Middle East & Africa Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 120 Middle East & Africa Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 121 Middle East & Africa Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 122 Middle East & Africa Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 123 Middle East & Africa Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 124 Middle East & Africa Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 125 Middle East & Africa Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 126 Middle East & Africa Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 127 Middle East & Africa Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 128 Middle East & Africa Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 132 Middle East & Africa Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)